PositiveID begins producing PCR chips for Firefly DX cartridges
The handheld device provides detection and diagnostic information for pathogens using the PCR process within approximately 20 minutes. The company aims to provide an alternative to complicated laboratory tests that can be difficult or impossible to complete in the field.
The completion of these chips enables the company to advance to the next stages of the commercialization process. Now, the PCR chips will be produced in a cost-effective manner to increase their overall output.
“We continue to be encouraged by our sustained progress with the development and testing of the Firefly Dx prototype system,” PositiveID Chairman and CEO William Caragol said. “This latest milestone is significant because it allows us to make our PCR chips disposable, which, we believe, represents another proof statement that Firefly Dx can fill a critical requirement for point-of-need, rapid and cost-effective biological detection.”
While the primary application of the device would be in the medical field and in emergency response situations, the device would also be effective in the detection of contaminants in food and other sectors.